BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2011
View Archived Issues
FDA approves Oxford BioMedica's IND for UshStat trial
Read More
Exparel leads to sustained release of bupivacaine
Read More
Lilly begins phase II study of LY-2510924 in SCLC
Read More
New carbazole-linked hybrid antitumor agents prepared
Read More
Servier and Miragen enter research partnership for microRNA-targeted drugs
Read More
BeiGene in-licenses two clinical-stage oncology candidates
Read More
Ampio Pharmaceuticals reports clinical data on intranasal danazol
Read More
AstraZeneca and Forest Laboratories advance antibiotic combination CAZ-AVI
Read More
Vandetanib/bicalutamide combination trial does not meet primary endpoint
Read More
Phase II study assessed combination therapy containing rilotumumab in cancer
Read More
Korean scientists identify serum biomarkers of preeclampsia
Read More
Brazilian university designs new analgesic with in vivo activity
Read More
Clinical data analyses examine efficacy and safety of lorcaserin
Read More
Scientists at Prosidion prepare new ghrelin receptor ligands
Read More
Wisconsin Alumni Research Foundation patents new ligands of vitamin D receptor
Read More
Novel agents for HCV infection disclosed by Vertex
Read More
New protein kinase inhibitors presented by GSK
Read More
Abbott to split into two companies
Read More
Vertex submits Kalydeco NDA for priority review
Read More
Viralytics begins enrollment in phase II Cavatak trial following approval for dosing
Read More
FDA approves new indication for Byetta
Read More
FDA opens Cleveland BioLabs' IND for CBLB-502
Read More
Augment bone graft approved in Australia
Read More
Genticel completes recruitment in HPV vaccine trial
Read More
Syntaxin and Ipsen enter new global discovery and development collaboration
Read More